ZFP69B

gene
On this page

Also known as ZKSCAN23BFLJ34293ZSCAN54B

Summary

ZFP69B (ZFP69 zinc finger protein B, HGNC:28053) is a protein-coding gene on chromosome 1p34.2, encoding Zinc finger protein 69 homolog B (Q9UJL9). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in Golgi organization. Located in nucleolus.

Source: NCBI Gene 65243 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 70 total
  • MANE Select transcript: NM_023070

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28053
Approved symbolZFP69B
NameZFP69 zinc finger protein B
Location1p34.2
Locus typegene with protein product
StatusApproved
AliasesZKSCAN23B, FLJ34293, ZSCAN54B
Ensembl geneENSG00000187801
Ensembl biotypeprotein_coding
Entrez65243

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 7 protein_coding, 1 retained_intron

ENST00000361584, ENST00000411995, ENST00000469416, ENST00000484445, ENST00000863980, ENST00000863981, ENST00000961485, ENST00000961486

RefSeq mRNA: 2 — MANE Select: NM_023070 NM_001369565, NM_023070

CCDS: CCDS452

Canonical transcript exons

ENST00000361584 — 5 exons

ExonStartEnd
ENSE000036007134045420340454288
ENSE000036427734046242140463715
ENSE000038473134045047640451088
ENSE000038888294045734440457439
ENSE000038956814045694540457071

Expression profiles

Bgee: expression breadth ubiquitous, 170 present calls, max score 88.26.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.2832 / max 58.5584, expressed in 1206 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
23863.03071159
2014850.168058
23870.073628
23880.01093

Top tissues by expression

291 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.26gold quality
cortical plateUBERON:000534382.57gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.55gold quality
ganglionic eminenceUBERON:000402378.37gold quality
stromal cell of endometriumCL:000225574.00gold quality
ventricular zoneUBERON:000305372.28gold quality
islet of LangerhansUBERON:000000670.70gold quality
secondary oocyteCL:000065569.93gold quality
prefrontal cortexUBERON:000045168.63gold quality
embryoUBERON:000092266.73gold quality
oocyteCL:000002364.29gold quality
vermiform appendixUBERON:000115463.78gold quality
cingulate cortexUBERON:000302763.38gold quality
right frontal lobeUBERON:000281063.36gold quality
pancreasUBERON:000126463.16gold quality
anterior cingulate cortexUBERON:000983563.07gold quality
smooth muscle tissueUBERON:000113562.99gold quality
Brodmann (1909) area 9UBERON:001354062.97gold quality
nucleus accumbensUBERON:000188262.68gold quality
rectumUBERON:000105262.54gold quality
neocortexUBERON:000195062.54gold quality
gall bladderUBERON:000211062.48gold quality
frontal cortexUBERON:000187062.05gold quality
bone marrow cellCL:000209261.06gold quality
dorsolateral prefrontal cortexUBERON:000983460.94gold quality
lymph nodeUBERON:000002960.64gold quality
caudate nucleusUBERON:000187360.33gold quality
body of pancreasUBERON:000115060.16gold quality
caecumUBERON:000115360.15gold quality
leukocyteCL:000073860.07gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-6142no36.53
E-ANND-3no1.87

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

7 targeting ZFP69B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-129099.5969.902079
HSA-MIR-181A-2-3P98.9167.601168
HSA-MIR-124698.5466.21959
HSA-MIR-376A-5P97.7065.61863
HSA-MIR-376C-3P97.6368.881263
HSA-MIR-1212896.6766.981471
HSA-MIR-6834-5P96.2564.88823

Literature-anchored findings (GeneRIF, showing 1)

  • ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes. (PMID:38003570)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)

Protein

Protein identifiers

Zinc finger protein 69 homolog BQ9UJL9 (reviewed: Q9UJL9)

Alternative names: Zinc finger protein 643

All UniProt accessions (2): E9PS66, Q9UJL9

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation. Essential for Golgi structural integrity.

Subcellular location. Nucleus.

Induction. Up-regulated by Golgi stress-inducing agent nigericin.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9UJL9-11yes
Q9UJL9-22

RefSeq proteins (2): NP_001356494, NP_075558* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR003309SCAN_domDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352, PF13465

UniProt features (18 total): zinc finger region 9, cross-link 4, sequence variant 2, chain 1, domain 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9UJL9-F163.170.13

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (4): 37, 40, 178, 235

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 59 (showing top): YAGI_AML_WITH_INV_16_TRANSLOCATION, chr1p34, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, HUANG_FOXA2_TARGETS_UP, GOBP_GOLGI_ORGANIZATION, GOCC_NUCLEOLUS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, HATADA_METHYLATED_IN_LUNG_CANCER_UP, VERHAAK_GLIOBLASTOMA_PRONEURAL, PEDRIOLI_MIR31_TARGETS_UP, PHONG_TNF_RESPONSE_VIA_P38_COMPLETE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF528_TARGET_GENES, ZNF610_TARGET_GENES, ZSCAN30_TARGET_GENES

GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), Golgi organization (GO:0007030), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (3): nucleus (GO:0005634), nucleolus (GO:0005730), nuclear lumen (GO:0031981)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
organelle organization1
endomembrane system organization1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular membraneless organelle1
nucleus1
intracellular organelle lumen1

Protein interactions and networks

STRING

340 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZFP69BC3orf70A6NLC5507
ZFP69BSMAP2Q8WU79507
ZFP69BC16orf96A6NNT2433
ZFP69BELFN2Q5R3F8391
ZFP69BPOC1AQ8NBT0365
ZFP69BDCAF10Q5QP82352
ZFP69BCYTH4Q9UIA0349
ZFP69BZDHHC23Q8IYP9327
ZFP69BLYSMD3Q7Z3D4324
ZFP69BSORCS1Q8WY21320
ZFP69BNXPE3Q969Y0311
ZFP69BCILP2Q8IUL8311
ZFP69BSNED1Q8TER0305
ZFP69BFAM174BQ3ZCQ3305
ZFP69BKLHL6Q8WZ60301

IntAct

10 interactions, top by confidence:

ABTypeScore
KRT40ZFP69Bpsi-mi:“MI:0915”(physical association)0.560
PRPF31ZFP69Bpsi-mi:“MI:0915”(physical association)0.560
ZFP69BHNRNPA2B1psi-mi:“MI:0915”(physical association)0.400
ZFP69BHNRNPDLpsi-mi:“MI:0915”(physical association)0.400
ZFP69BCNPpsi-mi:“MI:0914”(association)0.350
PRPF31ZFP69Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (13): KRT40 (Two-hybrid), ZFP69B (Affinity Capture-MS), ZFP69B (Two-hybrid), ZFP69B (Proximity Label-MS), ZFP69B (Proximity Label-MS), DBNL (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), UGT1A10 (Affinity Capture-MS), SMAD3 (Affinity Capture-MS), CNP (Affinity Capture-MS), KCTD16 (Affinity Capture-MS), CORO1A (Affinity Capture-MS), ZFP69B (Affinity Capture-MS)

ESM2 similar proteins: A0JPL0, A3KN36, A7MBI1, A8MT65, B2RXC5, D3ZVT0, P08042, P21506, P51508, P52738, Q02525, Q06730, Q12901, Q2KI58, Q2M218, Q2M3W8, Q2M3X9, Q2VY69, Q49AA0, Q4R6J4, Q4V8A8, Q5FWF6, Q5HY98, Q5RB33, Q5RC79, Q5REF1, Q5T5D7, Q5VIY5, Q61967, Q6P2D0, Q6ZN11, Q86XU0, Q86Y25, Q8N782, Q8N859, Q8NB42, Q8TF39, Q8TF47, Q8WXB4, Q95K49

Diamond homologs: A0A087WUV0, Q96K75, Q99676, Q9HBT8, Q9UJL9, Q9UJN7, A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

70 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance59
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

744 predictions. Top by Δscore:

VariantEffectΔscore
1:40451085:GAAG:Gdonor_gain1.0000
1:40454201:A:AGacceptor_gain1.0000
1:40454202:G:GGacceptor_gain1.0000
1:40456939:TTCTA:Tacceptor_loss1.0000
1:40456940:TCTA:Tacceptor_loss1.0000
1:40456941:CTA:Cacceptor_loss1.0000
1:40456942:TA:Tacceptor_loss1.0000
1:40457067:AGTGG:Adonor_loss1.0000
1:40457068:GTGG:Gdonor_gain1.0000
1:40457070:GG:Gdonor_gain1.0000
1:40457071:GG:Gdonor_gain1.0000
1:40451087:AGG:Adonor_loss0.9900
1:40451089:G:Cdonor_loss0.9900
1:40451089:G:GGdonor_gain0.9900
1:40454284:CCCAG:Cdonor_loss0.9900
1:40454285:CCAGG:Cdonor_loss0.9900
1:40454286:CAGGT:Cdonor_loss0.9900
1:40454287:AG:Adonor_loss0.9900
1:40454288:GG:Gdonor_loss0.9900
1:40454290:T:Adonor_loss0.9900
1:40456938:GTTCT:Gacceptor_loss0.9900
1:40456943:A:AGacceptor_gain0.9900
1:40456944:G:GGacceptor_gain0.9900
1:40457032:G:GTdonor_gain0.9900
1:40457032:G:Tdonor_gain0.9900
1:40457038:A:AGdonor_gain0.9900
1:40457072:G:GGdonor_gain0.9900
1:40457073:T:TCdonor_loss0.9900
1:40457077:G:GTdonor_gain0.9900
1:40457339:A:Gacceptor_gain0.9900

AlphaMissense

3550 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:40462930:T:CF316L0.999
1:40462932:T:AF316L0.999
1:40462932:T:GF316L0.999
1:40463350:T:CF456L0.999
1:40463352:T:AF456L0.999
1:40463352:T:GF456L0.999
1:40463014:T:CF344L0.998
1:40463016:C:AF344L0.998
1:40463016:C:GF344L0.998
1:40463098:T:CF372L0.998
1:40463100:C:AF372L0.998
1:40463100:C:GF372L0.998
1:40463266:T:CF428L0.998
1:40463268:C:AF428L0.998
1:40463268:C:GF428L0.998
1:40463434:T:CF484L0.998
1:40463436:T:AF484L0.998
1:40463436:T:GF484L0.998
1:40463293:C:GH437D0.997
1:40463369:T:CL462P0.997
1:40463377:C:GH465D0.997
1:40463518:T:CF512L0.997
1:40463520:C:AF512L0.997
1:40463520:C:GF512L0.997
1:40462971:T:AH329Q0.996
1:40462971:T:GH329Q0.996
1:40463033:T:CL350P0.996
1:40463043:T:AH353Q0.996
1:40463043:T:GH353Q0.996
1:40463117:T:CL378P0.996

dbSNP variants (sampled 300 via entrez): RS1000057720 (1:40452814 C>T), RS1000088450 (1:40452495 C>T), RS1000354739 (1:40459277 T>G), RS1000694220 (1:40464072 C>G,T), RS1000707415 (1:40450283 T>A,G), RS1000759356 (1:40450528 G>A), RS1001432361 (1:40458464 G>A), RS1002275040 (1:40452352 A>G), RS1002306116 (1:40451988 G>A), RS1002639741 (1:40450476 G>A), RS1002824216 (1:40463809 A>G), RS1002878150 (1:40463462 A>C,G), RS1003132407 (1:40457211 T>C), RS1003184198 (1:40458419 C>T), RS1003212345 (1:40448934 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006658_11Longevity3.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, increases expression4
Valproic Acidaffects cotreatment, decreases expression, affects expression4
Cyclosporineaffects expression, increases expression4
trichostatin Aaffects cotreatment, decreases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Tetrachlorodibenzodioxindecreases expression2
Aflatoxin B1decreases expression, affects expression2
TAK-243increases sumoylation1
methylmercuric chlorideincreases expression1
triphenyl phosphateaffects expression1
bisphenol Aincreases expression1
terbufosdecreases methylation1
resorcinoldecreases expression1
S-(1,2-dichlorovinyl)cysteineincreases expression1
avobenzonedecreases expression1
di-n-butylphosphoric acidaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Air Pollutantsincreases abundance, increases expression1
Fonofosdecreases methylation1
Estradiolaffects cotreatment, increases expression1
N-Nitrosopyrrolidineincreases expression1
Parathiondecreases methylation1
Quercetindecreases expression1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
Oxyquinolinedecreases expression1
Okadaic Acidincreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XV97HEK293 eGFP-ZFP69BTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.